ArticleESMO open2024

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.

Y M Geurts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.